Gregory A. Deye

National Institute of Allergy and Infectious Diseases

Also affiliated with AstraZeneca (United States)

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19”.

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

New England Journal of Medicine(2020)10.1056/nejmoa2031994

N/A

6.8DataRank · unranked

1924 citations

Thomas F. Patterson, Aneesh K. Mehta, Kay M Tomashek, Cameron R. Wolfe, Varduhi Ghazaryan +55 more

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

PLoS Pathogens(2021)10.1371/journal.ppat.1009594

N/A

1.5DataRank · unranked

60 citations

Gregory A. Deye, B. Kim Lee Sim, Shirley Galbiati, Jessie K. Kennedy, Kristen W. Cohen +9 more

Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01018-20

N/A

1.1DataRank · unranked

27 citations

Shirley Galbiati, Jessie K. Kennedy, Gregory A. Deye, Effie Nomicos, Ellen E. Codd +7 more

Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing

Vaccine(2021)10.1016/j.vaccine.2020.12.023

N/A

0.981DataRank · unranked

23 citations

Andrea A. Berry, Mark A. Travassos, Catherine Cox, Yingjun Zhou, Annie X. Mo +5 more

EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil

Trials(2022)10.1186/s13063-022-05997-4

N/A

0.941DataRank · unranked

31 citations

Gail E. Potter, Matt D. T. Hitchings, Ellie Butler, Michelle Wiles, Jessie K. Kennedy +13 more

PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial

EClinicalMedicine(2022)10.1016/j.eclinm.2022.101579

N/A

0.933DataRank · unranked

30 citations

Abdoulaye K. Koné, Karim Traoré, Amadou Niangaly, Bourèma Kouriba, Charles Arama +19 more

A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection

Science Translational Medicine(2022)10.1126/scitranslmed.abn9709

N/A

0.590DataRank · unranked

50 citations

Ashley M. Vaughan, James G. Kublin, Matthew Fishbauger, Annette M. Seilie, Kurtis P. Cruz +20 more

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

Annals of Internal Medicine(2022)10.7326/m22-2116

N/A

0.434DataRank · unranked

6 citations

Tyler Bonnett, Kevin Rubenstein, David A Lindholm, Rekha R. Rapaka, Sarah B. Doernberg +39 more

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2

Annals of Internal Medicine(2024)10.7326/m23-2593

N/A

0.376DataRank · unranked

6 citations

Jing Wang, Kay M. Tomashek, Tyler Bonnett, Kanal Singh, Vincent C. Marconi +16 more

Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae062

N/A

0.344DataRank · unranked

7 citations

Andrea A. Berry, Mark A. Travassos, Mallory Shriver, Catherine Cox, Jessica Butts +12 more

Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions

Infectious Diseases and Therapy(2022)10.1007/s40121-022-00605-z

N/A

0.315DataRank · unranked

4 citations

Shruti M. Raja, Rachel L. Randell, Gregory A. Deye, Thomas Conrad, Aya Nakamura +6 more

Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?

Malaria Journal(2023)10.1186/s12936-023-04802-0

N/A

0.104DataRank · unranked

1 citations

Viviane Callier, Biraj Shrestha, Sudhaunshu Joshi, Ankit Dwivedi, Joana C. Silva +4 more

Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?

Research Square(2023)10.21203/rs.3.rs-3370731/v1

N/A

0DataRank · unranked

0 citations

Viviane Callier, Biraj Shrestha, Sudhaunshu Joshi, Ankit Dwivedi, Joana C. Silva +4 more

Population Pharmacokinetic Model of Oxfendazole and Metabolites in Healthy Adults following Single Ascending Doses

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.02129-20

N/A

0DataRank · unranked

7 citations

Daryl J. Murry, Larissa V. Stebounova, Gregory A. Deye, Patricia Winokur, Guohua An +1 more

Controlled human malaria infection with NF54 and 7G8 strains elicit differential antibody responses to Plasmodium falciparum peptides

Frontiers in Immunology(2025)10.3389/fimmu.2025.1641280

N/A

0DataRank · unranked

0 citations

Travis L. Jensen, Kirsten E. Lyke, Matthew B. Laurens, Joana C. Silva, Emily M. Stucke +15 more